Antigenic relationships among some animal rotaviruses: virus neutralization in vitro and cross-protection in piglets.

Journal of Clinical Microbiology
S K GaulR W Fulton


The serotype, RNA electropherotype, and cross-protection properties of rotaviruses isolated from canine, simian, porcine, and human species were compared. The bovine strain B:USA:78:1A and the canine strain C:USA:81:2 were adapted to cell culture and cloned in this study. The other viruses, i.e., simian strain S:USA:79:2, porcine Ohio State University strain P:USA:77:1, and human strain WA, were already cell culture adapted, although they were further cloned for this work. The serum neutralization test was used to classify the viruses into serotype groups. Viruses which exhibited a difference of 20-fold or greater in neutralization titer were separated into different serotype groups. In this study, four major serotype groups were found, and these groups were represented by bovine, human, porcine, and canine-simian strains. From cross-protection studies, these serotype groups were found to be significantly different. With the exception of the porcine strain, none of the viruses used as vaccines protected gnotobiotic piglets from challenge with the virulent porcine Ohio State University strain of rotavirus. Furthermore, the canine virus protected piglets from challenge with the simian virus. The RNA electropherotype confirmed tha...Continue Reading


Feb 1, 1977·Journal of Medical Microbiology·B D SchoubO W Prozesky
Jan 7, 1978·Lancet·G Zissis, J P Lambert
Jan 7, 1978·Lancet·M E ThoulessT H Flewett
Dec 1, 1978·Journal of Clinical Microbiology·J C Bridger
Jan 1, 1979·Archives of Virology·M S McNultyJ B McFerran
May 1, 1976·The Journal of General Virology·J C Bridger, G N Woode
May 1, 1976·Journal of Medical Microbiology·G N WoodeG Jackson
Apr 1, 1978·Canadian Journal of Microbiology·L SpenceL A Babiuk
Nov 23, 1978·The New England Journal of Medicine·R H YolkenR M Chanock
Jan 6, 1979·The Veterinary Record·R C JonesR R Henry
Nov 1, 1975·Journal of Medical Microbiology·J C BridgerH Davies
Jan 11, 1980·Science·R G WyattR M Chanock
Jan 1, 1980·Journal of Clinical Microbiology·G Zissis, J P Lambert
Feb 1, 1980·Journal of Clinical Microbiology·G StukerN J Schmidt
Jun 1, 1980·The Australian Journal of Experimental Biology and Medical Science·S R TziporiM L Smith
Jan 1, 1980·Journal of Medical Virology·G M BeardsT H Flewett
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H B GreenbergR M Chanock
Jun 1, 1981·The Journal of General Virology·Y HoshinoF W Scott
Oct 1, 1981·The Journal of General Virology·E Novo, J Esparza

❮ Previous
Next ❯


Mar 1, 1992·Veterinary Pathology·H B Gelberg
Jun 1, 1988·Epidemiology and Infection·N MinamotoY Suzuki
Sep 10, 2016·World Journal of Gastroenterology : WJG·Jin-Tao LiYu-Zhang Wu
Jan 1, 1984·Archives of Virology·C K OjehA J Herring
Mar 1, 1986·Archives of Disease in Childhood·T H Flewett
Oct 1, 1992·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·H J Van KruiningenL L Harris
Mar 1, 1988·European Journal of Epidemiology·G M Beards, D W Brown
Aug 1, 1983·Journal of Clinical Microbiology·R G WyattA Z Kapikian
Sep 1, 1983·Journal of Clinical Microbiology·Y HoshinoA Z Kapikian
Nov 1, 1989·Journal of Clinical Microbiology·R C BellinzoniE A Scodeller
Dec 1, 1989·Journal of Clinical Microbiology·G M BeardsT H Flewett
Sep 1, 1984·Journal of Clinical Microbiology·D R SnodgrassA J Herring
Jun 1, 1984·Microbiological Reviews·G Cukor, N R Blacklow
May 1, 1984·Journal of Clinical Microbiology·G N WoodeJ A Fagerland
May 1, 1983·Journal of Virology·B B MasonM K Estes
Nov 1, 1988·Journal of Clinical Microbiology·D W BrownV I Mathan
May 1, 1991·Journal of Clinical Microbiology·M E HardyD G Powell
Oct 1, 1990·Clinical Microbiology Reviews·R E Holland
Sep 1, 1983·Infection and Immunity·Y HoshinoA Z Kapikian
Dec 1, 1986·Journal of Clinical Microbiology·R F BishopG L Barnes
Jul 1, 1984·Journal of Virology·P A OffitS A Plotkin
Sep 1, 1987·Journal of Clinical Microbiology·H F ClarkP A Offit
Oct 1, 1989·Experimental and Molecular Pathology·M K IjazL A Babiuk

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.